NewEdge Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31K | Hold |
130
| – | – | ﹤0.01% | 3588 |
|
|
2025
Q1 | $2.32K | Hold |
130
| – | – | ﹤0.01% | 3479 |
|
|
2024
Q4 | $3.87K | Hold |
130
| – | – | ﹤0.01% | 3298 |
|
|
2024
Q3 | $2.03K | Hold |
130
| – | – | ﹤0.01% | 3380 |
|
|
2024
Q2 | $2.23K | Hold |
130
| – | – | ﹤0.01% | 3309 |
|
|
2024
Q1 | $2.03K | Hold |
130
| – | – | ﹤0.01% | 3366 |
|
|
2023
Q4 | $1.94K | Hold |
130
| – | – | ﹤0.01% | 3344 |
|
|
2023
Q3 | $2.1K | Hold |
130
| – | – | ﹤0.01% | 3035 |
|
|
2023
Q2 | $5.4K | Hold |
130
| – | – | ﹤0.01% | 2786 |
|
|
2023
Q1 | $7.82K | Sell |
130
-115
| -47% | -$6.92K | ﹤0.01% | 2643 |
|
|
2022
Q4 | $8.23K | Buy |
+245
| New | +$8.23K | ﹤0.01% | 2431 |
|
|
2020
Q4 | – | Sell |
-3,699
| Closed | -$412K | – | 1055 |
|
|
2020
Q3 | $412K | Buy |
+3,699
| New | +$412K | 0.01% | 632 |
|
|
2020
Q2 | – | Sell |
-3,108
| Closed | -$209K | – | 922 |
|
|
2020
Q1 | $209K | Buy |
+3,108
| New | +$209K | 0.01% | 694 |
|